Description de fonction

IJB A07/21 : Open position for a Fellowship in Clinical Cancer Research for the Oncodistinct network and the Clinical Trials Conduct Unit (CTCU)

Détails de la société

The Oncodistinct network was created in 2015 at the initiative of cancer centres in and outside of Europe. It is based at Institut Jules Bordet, in Brussels. The network aims to respond to the exponential changes in the oncology research landscape by accelerating treatment individualization, promoting multidisciplinarity, in clinical research and challenging current practices, particularly in settings with unmet medical needs. Oncodistinct is a research network bringing together leading academic investigators who share the same vision of innovative clinical research. By building a strong collaboration between clinicians, scientists and partners in drug development, Oncodistinct develops early-to-later phase clinical trials with innovative designs and cutting-edge translational research components, all aiming to significantly improve patient outcomes. As of right now, Oncodistinct has 5 active clinical trials, and 3 upcoming clinical trials in many European sites and Middle East region. The driving force of the network is its investigators’ think tank which generates innovative clinical research projects. Oversight and strategy decision making come from Oncodistinct steering committee which is composed of one representative per Oncodistinct centre. The day-to-day management of activities is supported by coordinating and operational teams.

The Clinical Trials Conduct Unit (CTCU) conducts clinical studies in a professional manner, in compliance with European Directives, regulations and Good Clinical Practice – GCP). These clinical studies are carried out in collaboration with pharmaceutical firms and/or academic partners. The clinical studies conducted at the Institut Bordet are coordinated by CTCU research physicians and teams. These doctors are responsible for monitoring patients and collecting data.

Fonction

The mission is two-fold :

The Oncodistinct network is seeking a highly motivated and dynamic fellow to conduct academic research as well as other activities within the network and the Clinical Trials Conduct Unit (CTCU) of Institut Jules Bordet (on a 50-50% basis). The fellow will be involved in all stages of different Oncodistinct clinical trials (from set up to follow up), and will gain expertise in conducting trials through participation in the activities of the Clinical Trial Conduct Unit (CTCU) of Institut Jules Bordet.

The fellow will be mentored by Prof. Ahmad Awada (Head of the Oncology Medicine Department, Institut Jules Bordet) and supervised by Dr Nuria Kotecki (Oncodistinct Executive Officer and medical oncologist at Institut Jules Bordet in charge of the early drug development program at CTCU) and Dr Philippe Aftimos (Head of the CTCU).

The fellow will be encouraged to develop his own clinical trial (in which he can benefit from the expertise of all the members of the Oncodistinct network, from conception to execution), and to participate to workshops (e.g.: Flims Alumni Club – MCCR).

Primary responsibilities :

Clinical work:

  • Research fellowship that includes also clinical research activities as described in the application.
  • Full-time junior “Clinical Research Physician” (CRP).
  • Provide support for the medical follow-up of ongoing Oncodistinct studies in interaction with other oncologists
  • Start his/her own clinical study within the network.
  • Write reviews and/or articles on scientific subjects of interest for the Oncodistinct network.
  • Participate to fundraising actions for the network (grants, calls…).
  • Represent the Oncodistinct network at events (scientific congresses, etc.).
  • The fellow will work in close collaboration with the Project Manager, the Coordinating Team and the Executive Officer of the network.
  • Participation to the clinical activities within the Clinical Trial Conduct Unit at Institut Jules Bordet (e.g.: Follow-up of patients included in a study, participation in study teleconferences, medical support for study coordinators)

Profil

To be eligible, candidates must :

Essential qualifications and skills:

  • The fellow must be a qualified oncologist, or oncologist in training with at least two years of clinical experience in medical oncology.
  • Be interested in clinical research for his/her career.
  • Excellent command of written & spoken English.
  • Ability to work well within a team.
  • Strong organizational, communication, interpersonal and presentation skills.
  • Analytical and problem-solving skills.
  • The fellow must be eligible to work in Belgium or have a work permit.

Desirable skills:

  • Experience in clinical trials is a plus.
  • Experience with an EU cancer network is an asset.
  • Good knowledge of French language is a plus.

Application process & selection :

Please send curriculum vitae, and a motivation letter. There will be a selection committee delegated with the task. Only shortlisted candidates will be contacted for an online interview.

Application closing date : 30 June 2021

Start date : November 2021

Duration of fellowship : 1 year with possibility to extend to 2 years (renewed based on performance)

Note : All documents must be submitted in English. Incomplete submissions will not be considered.

For more information on the position, please send an email to oncodistinct@bordet.be. You can have a look at the network here: www.oncodistinct.net and here: https://www.bordet.be/

  • Publiée le:ven. 26 mars 2021
  • Lieu: Institut Jules Bordet
E-mail
Veuillez patienter durant le traitement de votre demande
Mail vers vos amis
Mail(s) envoyé avec succès
Une erreur c'est produite, veuillez contacter votre administrateur système
[fermer]